Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Single and Multiple-Dose Safety and Pharmacokinetic and Drug -261025120
Fox Chase Cancer Center /Inc/
Search grants from Fox Chase Cancer Center /Inc/
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Neutrophil Extracellular Traps in the Lung and Development of Rheumatoid Arthritis-Related Autoimmunity and Arthritis
Ultra-fast Mri For Cardiovascular Applications
Predictiing Joint Degeneration
RUI: Strong tests of life history theory using experimental reduction of embryo energy content in diverse marine invertebrates
Continuation of the XENON100 Dark Matter Search at the Gran Sasso Underground Laboratory
Recently added grants:
Defining the role of microbiota-derived cyclic dinucleotides in priming antiviral immune defenses.
The c-Rel Checkpoint for Immunosuppression and Immunotherapy
Inflammation in Rotator Cuff Tear and Repair
Neutrophil Extracellular Traps in the Lung and Development of Rheumatoid Arthritis-Related Autoimmunity and Arthritis
Mechanisms of DUX4 mediated FSHD pathology
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN025120-003
Application #
7191429
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2005
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center /Inc/
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic and Drug -261025120
/ Fox Chase Cancer Center /Inc/
NIH 2005
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic and Drug -261025120
/ Fox Chase Cancer Center /Inc/
NIH 2004
N01 CN
Phase I. in Vivo and IN Vitro Pharmacology of A Chemopreventive Agent -261025120
/ Fox Chase Cancer Center /Inc/
Comments
Be the first to comment on this grant